Russell Kevin Klass
CIK 1999774 · Sr. Vice President, Sales · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
17
Lifetime Open-Market Net
$211.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Zomedica Corp. (ZOM) Delisted | Sr Vice President of Sales | 1,500,050 | $0.10 | $146.0K | $211.9K | 6 | 2025-02-24 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-18 | — | Buy (P) | +699,980 | $49.0K | |
| 2025-02-24 | Zomedica Corp. (ZOM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-11-12 | Zomedica Corp. (ZOM) Delisted | Buy (P) | +500,000 | $60.3K | EDGAR |
| 2024-06-13 | Zomedica Corp. (ZOM) Delisted | Buy (P) | +299,993 | $46.5K | EDGAR |
| 2024-06-12 | Zomedica Corp. (ZOM) Delisted | Buy (P) | +700,007 | $105.0K | EDGAR |
| 2023-11-14 | Zomedica Corp. (ZOM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-09 | Zomedica Corp. (ZOM) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.